ADICON Clinical LaboratoryADICON Clinical Laboratory

Platform

 

Adicon has invested in new diagnostic technologies which fit for China’s market. Currently, R&D Center has over 30 research scientists.

The center conducts research and development in advanced molecular diagnostic techniques, new assays and test reagents.

The major technology platforms include 1st and 2nd generation of sequencing, real-time quantitative PCR, fluorescence in situ hybridization, immunohistochemistry and Luminex.

We focus on developing new technologies in areas of infectious diseases, oncology, hematology, and phamaco-genomics. We also work closely with ACONLAB’s R&D center to transfer some assays to manufacturing process.

 

Technology Platform

1.Pyosequencing

    SNP,mutations,insertion/deletion,STR and multi-copy genes.

2.Real-time fluorescence quantitative PCR

    Hepatitis,hematologic,disorders,infectious disease,oncology

3.Fluorescence in situ Hybridization(FISH)

    Prenatal diagnosis,detection of solid tumors,blood cancer detection

4.Immunohistochemistry

    Detection of FFPE tissue sections from human disease,cell smear and xenograft

5.DNA sequencing

    Gene sequencing,genotype analysis,SNP,etc

6.Luminex

    Immunoassay,nucleic acid analysis,enzymatic analysis,receptor and ligand recognition

7. Remote Pathology Consultation System

     

    Remote pathology consultation, distance learning, internet based resources of database,etc